Filing Details

Accession Number:
0001179110-13-007302
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-29 13:11:37
Reporting Period:
2013-04-25
Filing Date:
2013-04-29
Accepted Time:
2013-04-29 13:11:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203304 G Jerry Mcclain 3838 West Parkway Blvd
Salt Lake City UT 84120
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-25 2,563 $26.06 2,563 No 4 M Direct
Common Stock Disposition 2013-04-25 2,563 $53.62 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2013-04-25 5,000 $0.00 5,000 $26.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-07-21 2014-01-21 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
  2. Average Price. Price range was $53.00 to 53.89.